2023
DOI: 10.15829/1560-4071-2023-5475
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and economic analysis of empagliflozin therapy in patients with heart failure across the ejection fraction range

Abstract: Aim. To evaluate the cost-effectiveness of empagliflozin therapy in patients with heart failure (HF) across the ejection fraction (EF) range in the Russian Fe­­deration.Material and methods. An analysis of the cost of HF management was carried out and an analytical decision-making model was built in MS Excel, which makes it possible estimating the costs of HF management with empagliflozin from the state position.Results. Taking into account the direct costs of adverse events, as well as indirect costs, the pot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 24 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?